Healthcare provider profile · identity verified

Joel Gonzalez, M.D.

Allopathic & Osteopathic Physicians|Internal Medicine · HOMESTEAD, FL · NPI 1902136617

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Joel Gonzalez, M.D. received $251.50 in general payments during 2025 across 6 reported records.

AstraZeneca Pharmaceuticals LP accounted for 71.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 51 claims for Brilinta by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 130 claims for Farxiga by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NEXIUM as an associated drug or biological on 464 records involving 299 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Nexium by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 111 claims for Symbicort by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$251.50

6 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$178.60	71.0%	3	2025
Sumitomo Pharma America, Inc.	Unresolved — no canonical attribution shown	$72.90	29.0%	3	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$251.50	6

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
BREZTRI Normalized: breztri	Drug	AstraZeneca Pharmaceuticals LP	$121.87	1	2025
Source payment records 2025-10-20 · AstraZeneca Pharmaceuticals LP · $121.87 · Open Payments source
GEMTESA Normalized: gemtesa	Drug	Sumitomo Pharma America, Inc.	$72.90	3	2025
Source payment records 2025-04-24 · Sumitomo Pharma America, Inc. · $24.30 · Open Payments source 2025-09-17 · Sumitomo Pharma America, Inc. · $24.30 · Open Payments source 2025-10-23 · Sumitomo Pharma America, Inc. · $24.30 · Open Payments source
FARXIGA Normalized: farxiga	Drug	AstraZeneca Pharmaceuticals LP	$24.59	1	2025
Source payment records 2025-08-06 · AstraZeneca Pharmaceuticals LP · $24.59 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
FARXIGA farxiga	2025	Farxiga	2024	130	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	BRILINTA open payments reported associated product	CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430	Brilinta · 2024 Exact normalized brand match · 1 Part D row	51	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	130	30
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	NEXIUM open payments reported associated product	CMS Open Payments — General Payments 464 supporting records · 299 recipient NPIs · example record 1206134180	Nexium · 2024 Exact normalized brand match · 1 Part D row	11	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	SYMBICORT open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610	Symbicort · 2024 Exact normalized brand match · 1 Part D row	111	60

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	953	281
Vitamin D2	Ergocalciferol (Vitamin D2)	680	229
Gabapentin	Gabapentin	575	173
Losartan Potassium	Losartan Potassium	553	169
Rosuvastatin Calcium	Rosuvastatin Calcium	518	169
Pantoprazole Sodium	Pantoprazole Sodium	498	159
Metformin Hcl	Metformin Hcl	474	136
Levothyroxine Sodium	Levothyroxine Sodium	434	124
Diclofenac Sodium	Diclofenac Sodium	407	113
Metoprolol Succinate	Metoprolol Succinate	348	99
Lisinopril	Lisinopril	345	102
Montelukast Sodium	Montelukast Sodium	333	102
Amlodipine Besylate	Amlodipine Besylate	332	101
Alcohol Prep Pads	Alcohol Antiseptic Pads	307	59
Alendronate Sodium	Alendronate Sodium	307	87
Tamsulosin Hcl	Tamsulosin Hcl	306	95
Temazepam	Temazepam	298	68
Omeprazole	Omeprazole	277	90
Fluticasone Propionate	Fluticasone Propionate	271	86
Eliquis	Apixaban	268	55
Januvia	Sitagliptin Phosphate	229	47
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	229	38
Furosemide	Furosemide	222	67
Famotidine	Famotidine	213	67
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	209	70
Alprazolam	Alprazolam	208	50
Diclofenac Potassium	Diclofenac Potassium	201	68
Memantine Hcl	Memantine Hcl	197	69
Sildenafil Citrate	Sildenafil Citrate	196	41
Celecoxib	Celecoxib	194	57
Mirtazapine	Mirtazapine	187	49
Azithromycin	Azithromycin	180	137
Albuterol Sulfate Hfa	Albuterol Sulfate	164	50
Tizanidine Hcl	Tizanidine Hcl	163	68
Tramadol Hcl	Tramadol Hcl	160	46
Clopidogrel	Clopidogrel Bisulfate	159	47
Metoprolol Tartrate	Metoprolol Tartrate	159	52
Escitalopram Oxalate	Escitalopram Oxalate	158	63
Ibuprofen	Ibuprofen	156	55
Ozempic	Semaglutide	147	31
Hydrochlorothiazide	Hydrochlorothiazide	144	45
Nifedipine Er	Nifedipine	144	45
Hydralazine Hcl	Hydralazine Hcl	143	42
Tadalafil	Tadalafil	143	35
Baclofen	Baclofen	136	55
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	135	43
Meclizine Hcl	Meclizine Hcl	134	53
Glipizide	Glipizide	131	43
Farxiga	Dapagliflozin Propanediol	130	30
Allopurinol	Allopurinol	117	39
Meloxicam	Meloxicam	117	42
Symbicort	Budesonide/Formoterol Fumarate	111	60
Sucralfate	Sucralfate	110	37
Folic Acid	Folic Acid	109	40
Valsartan	Valsartan	108	33
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	106	26
Methylprednisolone	Methylprednisolone	103	67
Sertraline Hcl	Sertraline Hcl	103	33
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	102	37
Carvedilol	Carvedilol	100	36
Finasteride	Finasteride	99	30
Latanoprost	Latanoprost	96	20
Mometasone Furoate	Mometasone Furoate	90	30
Clonidine Hcl	Clonidine Hcl	89	33
Quetiapine Fumarate	Quetiapine Fumarate	89	37
Tolterodine Tartrate Er	Tolterodine Tartrate	89	22
Novolog Flexpen	Insulin Aspart	88	15
Trazodone Hcl	Trazodone Hcl	86	35
Linzess	Linaclotide	82	23
Ezetimibe	Ezetimibe	81	29
Atenolol	Atenolol	80	26
Xarelto	Rivaroxaban	80	14
Ketoconazole	Ketoconazole	78	35
Jardiance	Empagliflozin	77	13
Entresto	Sacubitril/Valsartan	68	15
Cilostazol	Cilostazol	67	25
Ammonium Lactate	Ammonium Lactate	64	25
Chlorthalidone	Chlorthalidone	58	19
Enalapril Maleate	Enalapril Maleate	58	15
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	58	15
Metoclopramide Hcl	Metoclopramide Hcl	56	19
Prednisone	Prednisone	56	32
Clobetasol Propionate	Clobetasol Propionate	53	19
Fluoxetine Hcl	Fluoxetine Hcl	52	20
Mupirocin	Mupirocin	52	31
Brilinta	Ticagrelor	51	suppressed
Spiriva Handihaler	Tiotropium Bromide	51	suppressed
Testosterone Cypionate	Testosterone Cypionate	51	13
Duloxetine Hcl	Duloxetine Hcl	50	16
Simvastatin	Simvastatin	50	19
Gemfibrozil	Gemfibrozil	49	13
Esomeprazole Magnesium	Esomeprazole Magnesium	48	15
Megestrol Acetate	Megestrol Acetate	48	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	20
Citalopram Hbr	Citalopram Hydrobromide	46	16
Glimepiride	Glimepiride	45	15
Bumetanide	Bumetanide	44	18
Levofloxacin	Levofloxacin	44	33
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	17
Nebivolol Hcl	Nebivolol Hcl	44	12
Janumet	Sitagliptin Phos/Metformin Hcl	43	suppressed
Clonazepam	Clonazepam	42	11
Dicyclomine Hcl	Dicyclomine Hcl	42	15
Potassium Chloride	Potassium Chloride	42	11
Topiramate	Topiramate	42	16
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	42	13
Zolpidem Tartrate	Zolpidem Tartrate	41	14
Buspirone Hcl	Buspirone Hcl	40	14
Colchicine	Colchicine	40	11
Pentoxifylline	Pentoxifylline	40	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	suppressed
Ssd	Silver Sulfadiazine	39	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Breyna	Budesonide/Formoterol Fumarate	37	24
Ciclopirox	Ciclopirox	37	15
Comfort Ez Pen Needle	Pen Needle, Diabetic	37	suppressed
Donepezil Hcl	Donepezil Hcl	36	14
Methocarbamol	Methocarbamol	36	17
Solifenacin Succinate	Solifenacin Succinate	36	11
Azelastine Hcl	Azelastine Hcl	35	11
Carbidopa-Levodopa	Carbidopa/Levodopa	35	13
Spironolactone	Spironolactone	35	12
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	34	suppressed
Nitroglycerin	Nitroglycerin	34	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	29
Glipizide Er	Glipizide	32	11
Humalog Kwikpen U-100	Insulin Lispro	32	suppressed
Ondansetron Odt	Ondansetron	32	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	26
Cephalexin	Cephalexin	31	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Midodrine Hcl	Midodrine Hcl	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	30	suppressed
Tresiba Flextouch U-100	Insulin Degludec	30	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	30	suppressed
Dexlansoprazole Dr	Dexlansoprazole	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	25
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Ciclopirox	Ciclopirox Olamine	28	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Lovaza	Omega-3 Acid Ethyl Esters	28	suppressed
Methotrexate	Methotrexate Sodium	28	suppressed
Nystatin	Nystatin	28	16
Pioglitazone Hcl	Pioglitazone Hcl	28	11
Pregabalin	Pregabalin	28	suppressed
Restasis	Cyclosporine	28	suppressed
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Hydrocortisone	Hydrocortisone	27	12
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	25	suppressed
Procto-Med Hc	Hydrocortisone	25	suppressed
Single Use Swab	Alcohol Antiseptic Pads	25	15
Isosorbide Dinitrate	Isosorbide Dinitrate	24	suppressed
Telmisartan	Telmisartan	24	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	11
Prednisolone Acetate	Prednisolone Acetate	23	13
Trulicity	Dulaglutide	23	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Metronidazole	Metronidazole	22	21
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	11
Digoxin	Digoxin	21	suppressed
Naproxen	Naproxen	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Benzonatate	Benzonatate	20	15
Lumigan	Bimatoprost	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Sure Comfort Alcohol	Alcohol Antiseptic Pads	20	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	20	11
Estradiol	Estradiol	19	suppressed
Fluconazole	Fluconazole	19	17
Metolazone	Metolazone	19	12
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Sulfasalazine	Sulfasalazine	19	suppressed
Rytary	Carbidopa/Levodopa	18	suppressed
Timolol Maleate	Timolol Maleate	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Phenytoin	Phenytoin	17	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	16	suppressed
Estradiol (Twice Weekly)	Estradiol	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Methimazole	Methimazole	16	suppressed
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	15	14
Alcohol Swabs	Alcohol Antiseptic Pads	14	suppressed
Cefdinir	Cefdinir	14	11
Lactulose	Lactulose	14	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Nurtec Odt	Rimegepant Sulfate	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Trifluoperazine Hcl	Trifluoperazine Hcl	13	suppressed
Zenpep	Lipase/Protease/Amylase	13	suppressed
Comfort Ez Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Diphenhydramine Hcl	Diphenhydramine Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	11	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Multaq	Dronedarone Hcl	11	suppressed
Nexium	Esomeprazole Magnesium	11	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	11	suppressed
Scopolamine	Scopolamine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$251.50 · 6 records	AstraZeneca Pharmaceuticals LP	BREZTRI, FARXIGA, GEMTESA	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Farxiga play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error